• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴基斯坦卡拉奇一个非正式定居点丙型肝炎病毒感染的患病率及危险因素

Prevalence and risk factors for hepatitis C virus infection in an informal settlement in Karachi, Pakistan.

作者信息

Mansoor Munazza, de Glanville William A, Alam Ridwa, Aslam Khawar, Ahmed Mubashir, Isaakidis Petros, Pasha Aneeta

机构信息

Interactive Research and Development (IRD), Karachi, Pakistan.

Médecins Sans Frontières (MSF), Brussels, Belgium.

出版信息

PLOS Glob Public Health. 2023 Sep 20;3(9):e0002076. doi: 10.1371/journal.pgph.0002076. eCollection 2023.

DOI:10.1371/journal.pgph.0002076
PMID:37729129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10511086/
Abstract

The burden of hepatitis C virus (HCV) infection in Pakistan is amongst the highest in the world. People living in slums are likely to be at high risk of infection. Here, we describe the results of a cross-sectional survey conducted in March 2022 that aimed to quantify the prevalence of HCV infection in Machar Colony, one of the largest and oldest slum settlements in Karachi. Risk factors for HCV seropositivity were identified using multi-level logistic regression. We recruited 1,303 individuals in a random selection of 441 households from Machar Colony. The survey-adjusted HCV-seroprevalence was 13.5% (95% Confidence Interval (CI) 11.1-15.8) and survey-adjusted viraemic prevalence was 4.1% (95% CI 3.1-5.4) with a viraemic ratio of 32% (95% CI 24.3-40.5). Of 162 seropositive people, 71 (44%) reported receiving previous treatment for chronic hepatitis C. The odds of HCV seropositivity were found to increase with each additional reported therapeutic injection in the past 12 months (OR = 1.07 (95% Credible Interval (CrI) 1.00-1.13)). We found weaker evidence for a positive association between HCV seropositivity and a reported history of receiving a blood transfusion (OR = 1.72 (95% CrI 0.90-3.21)). The seroprevalence was more than double the previously reported seroprevalence in Sindh Province. The overall proportion of seropositive people that were viraemic was lower than expected. This may reflect the long-term impacts of a non-governmental clinic providing free of cost and easily accessible hepatitis C diagnosis and treatment to the population since 2015. Reuse of needles and syringes is likely to be an important driver of HCV transmission in this setting. Future public health interventions should address the expected risks associated with iatrogenic HCV transmission in this community.

摘要

巴基斯坦丙型肝炎病毒(HCV)感染负担位居世界前列。生活在贫民窟的人群感染风险可能很高。在此,我们描述了2022年3月进行的一项横断面调查结果,该调查旨在量化卡拉奇最大且最古老的贫民窟定居点之一马查尔殖民地HCV感染的患病率。使用多水平逻辑回归确定HCV血清阳性的危险因素。我们从马查尔殖民地随机选取441户家庭,招募了1303名个体。经调查调整后的HCV血清流行率为13.5%(95%置信区间(CI)11.1 - 15.8),经调查调整后的病毒血症流行率为4.1%(95%CI 3.1 - 5.4),病毒血症比率为32%(95%CI 24.3 - 40.5)。在162名血清阳性者中,71人(44%)报告曾接受过慢性丙型肝炎治疗。过去12个月内每增加一次报告的治疗性注射,HCV血清阳性的几率就会增加(比值比(OR)= 1.07(95%可信区间(CrI)1.00 - 1.13))。我们发现HCV血清阳性与报告的输血史之间存在正相关的证据较弱(OR = 1.72(95%CrI 0.90 - 3.21))。血清流行率比信德省之前报告的血清流行率高出一倍多。血清阳性且病毒血症患者的总体比例低于预期。这可能反映了自2015年以来一家非政府诊所为该人群提供免费且易于获得的丙型肝炎诊断和治疗所产生的长期影响。在这种情况下,针头和注射器的重复使用很可能是HCV传播的一个重要驱动因素。未来的公共卫生干预措施应应对该社区与医源性HCV传播相关的预期风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/10511086/7e830a210d07/pgph.0002076.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/10511086/c055d2a9e554/pgph.0002076.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/10511086/8dda019893bf/pgph.0002076.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/10511086/79cb0c514952/pgph.0002076.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/10511086/7e830a210d07/pgph.0002076.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/10511086/c055d2a9e554/pgph.0002076.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/10511086/8dda019893bf/pgph.0002076.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/10511086/79cb0c514952/pgph.0002076.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c7/10511086/7e830a210d07/pgph.0002076.g004.jpg

相似文献

1
Prevalence and risk factors for hepatitis C virus infection in an informal settlement in Karachi, Pakistan.巴基斯坦卡拉奇一个非正式定居点丙型肝炎病毒感染的患病率及危险因素
PLOS Glob Public Health. 2023 Sep 20;3(9):e0002076. doi: 10.1371/journal.pgph.0002076. eCollection 2023.
2
Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.澳大利亚注射吸毒人群中直接抗丙型肝炎病毒药物的快速使用与病毒血症流行率下降之间的关联。
J Hepatol. 2019 Jan;70(1):33-39. doi: 10.1016/j.jhep.2018.09.030. Epub 2018 Oct 25.
3
Hepatitis C viraemic and seroprevalence and risk factors for positivity in Northwest Cambodia: a household cross-sectional serosurvey.柬埔寨西北部丙型肝炎病毒血症、血清流行率及阳性危险因素:一项家庭横断面血清学调查
BMC Infect Dis. 2021 Feb 26;21(1):223. doi: 10.1186/s12879-021-05826-0.
4
High prevalence of hepatitis C virus infection in the largest province of Pakistan.巴基斯坦最大省份丙型肝炎病毒感染的高流行率。
J Dig Dis. 2008 May;9(2):95-103. doi: 10.1111/j.1751-2980.2008.00329.x.
5
Prevalence and risk factors for intrafamilial transmission of hepatitis C virus in Karachi, Pakistan.巴基斯坦卡拉奇丙型肝炎病毒家庭内传播的患病率及危险因素
J Viral Hepat. 2002 Jul;9(4):309-14. doi: 10.1046/j.1365-2893.2002.00350.x.
6
A CROSS-SECTIONAL SCREENING SURVEY ON THE SEROPREVALENCE OF HEPATITIS B AND HEPATITIS C AMONGST THE GENERAL POPULATION OF RURAL DISTRICTS OF SINDH, PAKISTAN.巴基斯坦信德省农村地区普通人群乙型肝炎和丙型肝炎血清流行率的横断面筛查调查。
Arq Gastroenterol. 2021 Apr-Jun;58(2):150-156. doi: 10.1590/S0004-2803.202100000-26.
7
Demographic determinants of hepatitis C virus seroprevalence among blood donors.献血者中丙型肝炎病毒血清流行率的人口统计学决定因素。
JAMA. 1996 Apr 3;275(13):995-1000.
8
Seroprevalence of hepatitis C and correlates of seropositivity among men who have sex with men in Vancouver, Canada: a cross-sectional survey.加拿大温哥华男男性行为者中丙型肝炎的血清流行率及血清阳性相关因素:一项横断面调查。
Sex Transm Infect. 2015 Sep;91(6):430-3. doi: 10.1136/sextrans-2014-051928. Epub 2015 Apr 14.
9
Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi, Pakistan.巴基斯坦卡拉奇无症状男性志愿献血者中的丙型肝炎病毒感染情况。
J Viral Hepat. 2004 Nov;11(6):527-35. doi: 10.1111/j.1365-2893.2004.00518.x.
10
Seroprevalence and risk factors for hepatitis C virus (HCV) infection in pregnant women attending public sector tertiary care hospital in Hyderabad Sindh.在信德省海得拉巴公立医院就诊的孕妇中丙型肝炎病毒 (HCV) 感染的血清流行率和危险因素。
Pak J Med Sci. 2013 Apr;29(2):505-8. doi: 10.12669/pjms.292.3211.

引用本文的文献

1
High Burden of Symptomatic and Asymptomatic Sexually Transmitted Infections in a Routine Decentralised HIV Care Setting in Eswatini: A Cross-Sectional Study.斯威士兰常规分散式艾滋病护理环境中症状性和无症状性传播感染的高负担:一项横断面研究
Trop Med Int Health. 2025 Sep;30(9):987-1005. doi: 10.1111/tmi.70011. Epub 2025 Jul 22.
2
A Health Systems Strengthening Approach to Address the High Burden of Hepatitis C in Pakistan.一种加强卫生系统的方法来应对巴基斯坦丙型肝炎的高负担。
J Viral Hepat. 2025 Jan;32(1):e14050. doi: 10.1111/jvh.14050.
3
Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years.

本文引用的文献

1
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.全球丙型肝炎病毒流行率的变化和 2015 年至 2020 年期间的治疗流程:建模研究。
Lancet Gastroenterol Hepatol. 2022 May;7(5):396-415. doi: 10.1016/S2468-1253(21)00472-6. Epub 2022 Feb 16.
2
Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis.在三个选定的世卫组织东地中海区域国家中注射吸毒者中 HIV 和 HCV 的流行率:一项荟萃分析。
Harm Reduct J. 2021 May 27;18(1):59. doi: 10.1186/s12954-021-00505-4.
3
Hepatitis C elimination in Pakistan is a distant dream unless government controls the health sector.
消除 HCV 感染:近年流行病学发现、障碍及未来策略。
Viruses. 2024 Nov 19;16(11):1792. doi: 10.3390/v16111792.
4
Usability and acceptability of self-testing for hepatitis C virus exposure in a high-prevalence urban informal settlement in Karachi, Pakistan.在巴基斯坦卡拉奇一个高患病率的城市非正规住区,对丙型肝炎病毒暴露进行自我检测的可用性和可接受性。
BMC Infect Dis. 2024 Sep 27;24(1):1054. doi: 10.1186/s12879-024-09925-6.
5
Correction: Prevalence and risk factors for hepatitis C virus infection in an informal settlement in Karachi, Pakistan.更正:巴基斯坦卡拉奇一个非正式定居点丙型肝炎病毒感染的患病率及危险因素
PLOS Glob Public Health. 2024 Jan 29;4(1):e0002897. doi: 10.1371/journal.pgph.0002897. eCollection 2024.
除非政府对卫生部门加以管控,否则在巴基斯坦消除丙型肝炎只是一个遥不可及的梦想。
J Pak Med Assoc. 2020 Dec;70(12(B)):2454-2456. doi: 10.47391/JPMA.384.
4
The phases of hepatitis C elimination: achieving WHO elimination targets.丙型肝炎消除的阶段:实现世界卫生组织的消除目标
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):6-8. doi: 10.1016/S2468-1253(20)30366-6.
5
Hepatitis C virus elimination: laying the foundation for achieving 2030 targets.丙型肝炎病毒消除:为实现 2030 年目标奠定基础。
Nat Rev Gastroenterol Hepatol. 2021 Feb;18(2):91-92. doi: 10.1038/s41575-020-00392-3.
6
A Systematic Review of Transfusion-Transmissible Infections Among Blood Donors and Associated Safety Challenges in Pakistan.巴基斯坦献血者中输血传播感染及其相关安全挑战的系统评价
J Blood Med. 2020 Nov 2;11:405-420. doi: 10.2147/JBM.S277541. eCollection 2020.
7
Reuse of syringes for therapeutic injections in Pakistan: rethinking determinants.巴基斯坦治疗性注射中重复使用注射器:重新思考决定因素。
East Mediterr Health J. 2020 Mar 24;26(3):283-289. doi: 10.26719/emhj.19.028.
8
The cost of eliminating hepatitis C in Pakistan.在巴基斯坦消除丙型肝炎的成本。
Lancet Glob Health. 2020 Mar;8(3):e323-e324. doi: 10.1016/S2214-109X(20)30036-X.
9
Clustering of hepatitis C virus antibody positivity within households and communities in Punjab, India.印度旁遮普邦家庭和社区内丙型肝炎病毒抗体阳性的聚集性。
Epidemiol Infect. 2019 Oct 7;147:e283. doi: 10.1017/S0950268819001705.
10
Infection control practices in blood banks of Pakistan.巴基斯坦血库的感染控制实践。
East Mediterr Health J. 2019 Jul 24;25(5):331-340. doi: 10.26719/emhj.18.051.